MEI vs RARE · rev $1.02B vs rev $350.0M
Methode Electronics Inc (MEI) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Methode Electronics Inc (MEI) is a electronic components company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported MEI revenue for 2026-05-02 was $1.02B. Net income was -$35.7M. Revenue was down 2.8% from 2025-05-03 to 2026-05-02. MEI currently screens at market cap $409.9M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
MEI currently screens at market cap $409.9M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the MEI and RARE stock pages for the full models.
Not investment advice.